Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-gated calcium channels (VGCCs) in pancreatic beta cells are essential membrane proteins that mediate the influx of calcium ions (Ca^{2+}) in response to membrane depolarization. This calcium entry is a critical trigger for insulin secretion, making these channels central to glucose homeostasis and beta-cell physiology. Several α1 subunits are expressed: L-type (CaV1.2, CaV1.3), P/Q-type (CaV2.1), N-type (CaV2.2), and R-type (CaV2.3), each contributing to the fine-tuned regulation of insulin release. Dysregulation or mutations in VGCC subunits can lead to abnormal insulin secretion and contribute to the pathogenesis of type 1 and type 2 diabetes.
Inhibition of calcium ion influx
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pancreatic Beta Cell Voltage-Gated Calcium Channel.